[1] |
张宁,马辉辉,王凡,等.脑胶质瘤患者MGMT启动子甲基化和IDH1突变与临床预后相关[J].基础医学与临床,2021,41:1476-1480.
|
[2] |
Liu C, Ma Y, Wang R, et al. LINC00987 knockdown inhibits the progression of acute myeloid leukemia by suppressing IGF2BP2-mediated PA2G4 expression[J].Anticancer Drugs, 2022, 33: e207-e217.
|
[3] |
Xiao R, Yang M, Tan Y, et al. Identification of five immune-related lncRNAs predicting survival and tumor microenvironment characteristics in breast cancer[J].Comput Math Methods Med, 2021, 2021: 6676692. doi:10.1155/2021/6676692.
|
[4] |
Chuang HY, Su YK, Liu HW, et al. Preclinical evidence of STAT3 inhibitor pacritinib overcoming temozolomide resistance via downregulating miR-21-enriched exosomes from M2 glioblastoma-associated macrophages[J]. Journal of Clinical Medicine, 2019, 8:959. doi:10.3390/jcm8070959.
|
[5] |
Han L, Li Z, Jiang Y, et al. SNHG29 regulates miR-223-3p/CTNND1 axis to promote glioblastoma progression via Wnt/β-catenin signaling pathway[J].Cancer Cell Int, 2019, 19: 345. doi:10.1186/s12935-019-1057-x.
|
[6] |
El-Sehemy A, Selvadurai H, Ortin-Martinez A, et al. Norrin mediates tumor-promoting and -suppressive effects in glioblastoma via Notch and Wnt[J].J Clin Invest, 2020, 130: 3069-3086.
|
[7] |
Cai S, Lu JX,Wang YP, et al. SH2B3, transcribed by STAT1, promotes glioblastoma progression through transducing IL-6/gp130 signaling to activate STAT3 signaling[J].Front Cell Dev Biol, 2021, 9: 606527-606527.
|
[8] |
张学政,吴冬冰,张学娟,等.胃癌细胞外泌体lncRNA LOXL1-AS1诱导M2型巨噬细胞极化功能及机制研究[J].现代肿瘤医学,2022,30:1374-1380.
|
[9] |
魏冲,姜志超,王昊天,等.来那度胺可抑制单核细胞向M2型巨噬细胞分化及相关细胞因子的分泌[J].基础医学与临床,2015,35:786-791.
|
[10] |
Ding Q, Shen L, Nie X, et al. miR-223-3p overexpression inhibits cell proliferation and migration by regulating inflammation-associated cytokines in glioblastomas[J].Pathol Res Pract, 2018, 214: 1330-1339.
|
[11] |
Jin X, Jeon HY, Joo KM, et al. Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation[J].Cancer Res, 2011, 71: 3066-3075.
|